Which large vessel occlusion is amenable to thrombectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Large vessel occlusions in the anterior circulation are amenable to thrombectomy.

Eligibility Criteria

The following criteria are used to select patients for mechanical thrombectomy:

  • DAWN trial eligibility criteria: clinical imaging mismatch (a combination of NIHSS score and imaging findings on CTP or DW-MRI) for patients with large anterior circulation vessel occlusion between 6 and 24 hours from last known normal 1.
  • DEFUSE 3 trial eligibility criteria: perfusion-core mismatch and maximum core size for patients with large anterior circulation occlusion 6 to 16 hours from last seen well 1.

Thrombectomy Procedure

The technical goal of the thrombectomy procedure is to achieve reperfusion to a modified Thrombolysis in Cerebral Infarction (mTICI) 2b/3 angiographic result to maximize the probability of a good functional clinical outcome 1.

Time to Reperfusion

Reduced time from symptom onset to reperfusion with endovascular therapies is highly associated with better clinical outcomes, and reperfusion to TICI grade 2b/3 should be achieved as early as possible within the therapeutic window 1.

Device Selection

Stent retrievers are indicated in preference to the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) device for mechanical thrombectomy 1.

Imaging Evaluation

For patients who otherwise meet criteria for endovascular treatment (EVT), a noninvasive intracranial vascular study is recommended during the initial imaging evaluation of the acute stroke patient, but should not delay IV alteplase if indicated 1. In patients who are potential candidates for mechanical thrombectomy, imaging of the extracranial carotid and vertebral arteries, in addition to the intracranial circulation, is reasonable to provide useful information on patient eligibility and endovascular procedural planning 1.

From the Research

Large Vessel Occlusion Amenable to Thrombectomy

  • Large vessel occlusions of the anterior circulation are amenable to thrombectomy, as shown in a study of 4029 stroke patients with anterior large vessel occlusions treated with thrombectomy between January 2015 and May 2020 2.
  • Thrombectomy is also beneficial for patients with large vessel occlusion strokes and minimal symptoms, with a study indicating that mechanical thrombectomy was associated with a favorable shift of NIHSS at discharge, as well as higher rates of independence at discharge and long-term follow-up 3.
  • The current evidence suggests that thrombectomy is indicated in all ischemic stroke with large vessel occlusion, with recent trials demonstrating efficacy and safety in patients with large core strokes and those with basilar occlusions up to 24 hours of last known well 4.
  • Patients with large vessel occlusions should be offered mechanical thrombectomy, with or without IV thrombolysis, in an extended window up to 24 hours of last known well, as it is a standard of care for a patient with an LVO 5.
  • Mechanical thrombectomy plays an important role in the management of patients with mild strokes due to LVO, particularly in those not eligible for IV tPA, with a systematic review and meta-analysis showing that mechanical thrombectomy and medical therapy with IV tPA led to better 90-day functional outcome 6.

Specific Vessel Occlusions

  • Terminal carotid/tandem occlusion is a risk factor for embolic complications, such as embolus to a new territory (ENT), and is associated with worse clinical outcomes 2.
  • Middle cerebral-M1/M2, intracranial carotid, anterior cerebral, or basilar artery occlusions are also amenable to thrombectomy, with studies showing benefits in patients with these types of occlusions 3, 4.
  • Basilar occlusions up to 24 hours of last known well are also eligible for thrombectomy, with recent trials demonstrating efficacy and safety in these patients 4.

Related Questions

What is the recommended approach for Large Vessel Occlusion (LVO) in the setting of a stroke when systemic thrombolytics are contraindicated?
What is the most appropriate oral antithrombotic therapy for a 73-year-old female with a history of hypertension, hyperlipidemia, type 2 diabetes mellitus, and smoking, presenting with symptoms of a stroke, including right facial droop, right-sided weakness and numbness, and global aphasia, with 80% stenosis in the left middle cerebral artery?
What is the next step in therapy for a patient presenting with symptoms of a stroke, last seen normal 5 hours ago, with a large vessel occlusion in an M1 distribution, no hemorrhage on CT brain scan, normal glucose, hypertension, and an National Institutes of Health Stroke Scale (NIHSS) score of 8?
Does the management of large vessel occlusion (LVO) due to vertebral artery dissection differ from standard LVO care?
Is alteplase (tissue-free plasminogen activator, tPA) indicated for a small acute right parietal infarct with no visible large vessel occlusion on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Angiography (MRA)?
What is the role of decortication in treating empyema?
Can Toxic Shock Syndrome (TSS) be treated with doxycycline?
What are the effects of an overdose of doxazosin?
What are the risks of overcorrecting hypernatremia?
Is Artemisia (black wormwood) effective against parasites?
Is there a law requiring doctors to disclose medical test results to patients within a certain time frame once available?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.